November 28, 2024 - 06:05

Researchers at the University of Twente, Netherlands, have made an advancement in bioprinting technology that could transform how we create vascularized tissues. Their innovative bioink enables precise 3D printing of blood vessels, paving the way for significant improvements in regenerative medicine and tissue engineering. This breakthrough could lead to enhanced methods for developing artificial organs and improving transplant success rates. The technology utilizes DNA-based materials to create a more accurate and functional representation of vascular structures, which are crucial for supplying nutrients and oxygen to tissues. As this research progresses, it holds the potential to greatly impact healthcare and the future of medical treatments.
June 25, 2026 - 07:54
ICON plc Selects Microsoft (MSFT) As Preferred Technology PartnerMicrosoft has been chosen by ICON plc as its preferred technology partner, a move that deepens the relationship between the two companies. The announcement, made on June 22, supports ICON`s...
June 24, 2026 - 22:13
NGPC Announces Partnership with Twiceme TechnologyThe AMA National Grand Prix Championship has announced a new partnership with Twiceme Technology, a company known for its smart safety gear, covering the 2026 and 2027 racing seasons. The deal aims...
June 24, 2026 - 13:29
The Human Touch in a Digital Age: Why AI Could Make Hospitality More PersonalAn industry strategist is making a bold prediction about the future of hotels and restaurants: artificial intelligence will reduce the total number of workers, but the people who remain on the...
June 23, 2026 - 19:02
ICON Technology Drops Invariant LLC Lobbying FirmAustin-based construction technology company ICON Technology has ended its working relationship with Invariant LLC, a prominent lobbying firm. The decision, confirmed through recent federal filings...